1 citations
,
May 2023 in “Revista Eletrônica Acervo Saúde” In this study, researchers reported that individuals with post-COVID-19 alopecia experienced a significant impact on their quality of life, particularly in the vitality domain, when compared to those without alopecia.
January 2023 in “Revista Eletrônica Acervo Saúde” This review reports that post-COVID telogen effluvium may be influenced by immune and psychological factors linked to COVID-19 infection, affecting hair loss.
April 2024 in “REVISTA INTERDISCIPLINAR CIÊNCIAS MÉDICAS” In this study, 41% of participants reported experiencing alopecia post-COVID-19, with notable associations found between the condition and female sex, azithromycin use, and symptoms like fatigue and post-infection skin irritation.
November 2025 in “Health Promotion Evidence” This study reviewed interventions for post-COVID-19 alopecia and concluded that integrated physiotherapeutic strategies, including photobiomodulation, micro-needling, electrotherapy, and scalp massage, can reduce hair loss and improve hair density, contributing positively to patient quality of life.
This study found a high prevalence of telogen effluvium among patients hospitalized for severe COVID-19, with most experiencing early onset and eventual complete hair regrowth.